FDA Approval Process for Brimonidine Tartrate by Micro Labs
The FDA has accepted the application ANDA218558 for Brimonidine Tartrate submitted by Micro Labs.
Therapeutic Area
Therapeutic area intelligence for Glaucoma with 20 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.